Novartis Ag (NVS) Non-Current Assets (2009 - 2026)

Novartis Ag has disclosed Non-Current Assets across 18 years of filings, most recently posting $94.7 billion for Q2 2026.

• In Q2 2026, Non-Current Assets rose 20.68% year-over-year to $94.7 billion; the TTM figure through Jun 2026 stood at $94.7 billion (up 20.68% YoY), while the FY2025 annual figure was $80.5 billion, up 10.96% from the prior year.
• Non-Current Assets came in at $94.7 billion for Q2 2026 at Novartis Ag, up from $91.9 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $94.7 billion in Q2 2026 to a low of $67.0 billion in Q3 2023.
• Average Non-Current Assets over 5 years is $78.5 billion, with a median of $78.8 billion recorded in 2025.
• Year-over-year, Non-Current Assets retreated 17.76% in 2023 and increased 22.84% in 2026.
• Over 5 years, Non-Current Assets stood at $80.5 billion in 2022, then declined by 13.76% to $69.5 billion in 2023, then climbed by 4.43% to $72.5 billion in 2024, then gained by 10.96% to $80.5 billion in 2025, then increased by 17.63% to $94.7 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $94.7 billion in Q2 2026, $91.9 billion in Q1 2026, and $80.5 billion in Q4 2025.